Community Acquired Pneumonia: 2019 New Guidelines Update
Dr. Olga Klinkova, Infectious Diseases Clinician at the Moffitt Cancer Center and Research Institute, discusses the recent updates to the diagnosis and management of community acquired pneumonia. Dr. Klinkova begins her talk by referring to the recently introduced IDSA-ATS guidelines, released in August, 2019. She then discusses updates in the microbiology of CAP, including the most likely organisms, the role of MRSA, atypicals and the significance of viral pathogens. She then mentions diagnostic modalities and the relevance of clinical prediction algorithms such as CURB-65 and the Pneumonia Severity Index (PSI). Treament considerations including outpatient versus inpatient, and inpatient non-severe versus inpatient severe management are also differentiated. Specific treatment agents and therapy durations are also mentioned. Lastly, she discusses options for the management of MRSA pneumonia and aspiration syndromes.
Stay in touch! Download our app on the iTunes store or find us below:
Subscribe to our KZread Channel: / idpodcasts
Visit us on our webpage: www.idpodcasts.net
Follow us on Facebook: / id-podcasts-. .
Tweet to us: / idpodcasts
Пікірлер: 19
Thank you so much for this update! I'm more of an oral learner so having someone present the information and telling me is much easier for me to learn than me reading through the guidelines and falling asleep every 5 mins haha
Excellent summation. Did you have any talks on Bone and Joint or Skin and Soft Tissue Infection?
Excellent review. Thanks
Excellent! A lecture about NPNA would be awesome!
Very very excellent and skillful
Thanks
This is so helpful
Thanx❤❤❤
Do you have updated soft copy cpg 2019?
I think the procalcitonin value is helpful for distinguishing viral from bacterial pneumonia . It makes no sense to treat more than half the patients, who have viruses, inappropriately with antibiotics? And I work in a community hospital, and 4 years as a hospitalist have never seen MRSA pneumonia.